Since 1926, Kearney has been a leading management consulting firm and trusted partner to three-quarters of the Fortune Global 500 and governments around the world. With a presence across more than 40 countries, our people make us who we are. We work impact first, tackling your toughest challenges with original thinking and a commitment to making change happen together. By your side, we deliver—value, results, impact. For more information, please visit www.kearney.com

For more information please visit https://www.delsitech.com/

For more information please visit https://www.extrupharm.com/

For more information please visit https://pituvia.com/

HeartcoR Solutions is a core lab focused on the collection, analysis, and reporting of cardiac safety and other physiological data in clinical trials. Providing flexibility, innovation, and quality, we support both site-based and decentralized clinical studies with certified technician analysis, MD overreads, and validated data delivery to support our customers’ global regulatory filings. For more information, please visit https://heartcorsolutions.com/

PatientWing helps biopharmaceutical sponsors and CROs accelerate patient enrollment in their clinical trials. With a focus on serious conditions, we find patients by employing direct-to-patient outreach methods and ensure patients enroll in your trial through our white glove enrollment services, catering to both patients and research sites. For more information, please visit www.patientwing.com

For biotech and pharma companies developing precision medicines, Sano Genetics is the precision patient platform that unifies recruitment, genetic testing, and long-term participant engagement into a modular, compliant, and data-rich solution. Sano’s end-to-end approach reduces risk, cost, and drop-out while building valuable, recontactable patient cohorts for now and the future. For more information, please visit www.sanogenetics.com

With 40+ years’ experience in drug delivery systems—autoinjectors, inhalers, wearables, and digital solutions—PA supports partners from design to market. Our integrated team and advanced labs excel in device innovation, connectivity, test equipment, device strategy, and combo product support to overcome complex challenges and deliver patient-focused solutions.

Xylome is a genetic engineering company with a focus on high-value and sustainable products for drug delivery and personal care. Our patented lead product is Large Lipid Body (LLB) Technology for hydrophobic active pharmaceutical ingredients. LLB Technology advances the state-of-the-art for particle-based delivery with significant advantages over liposomes and nanoparticles. GMP samples are available and Xylome is using LLB Techology for the development of a new class of antifungal for serious burns. As a metabolic engineering company, Xylome has an advanced platform for the expression of fats and oils, which are produced by precision fermentation of our nonconventional yeast. Our available portfolio and GMP samples include multiple forms of YOIL®️, a very pure, bioidentical replacement for RBD-palm oil.

Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine’s unique biology to provide more accessible, effective and sustainable solutions across the healthcare spectrum, from rare genetic disorders to the world’s most prevalent conditions. Syntis is rapidly advancing a pipeline of oral therapies engineered for targeted activity in the small intestine, the body’s nexus for metabolic control, digestion and drug absorption. Alongside its lead obesity program, SYNT-101, the company is advancing a portfolio of therapies targeting orphan metabolic diseases and intestinal-related disorders. Syntis is headquartered in Boston, MA.

Mitsubishi Gas Chemical (MGC) is a leading company in the field of oxygen barrier and absorbing polymers. Based on these technologies and experiences, MGC launched new multilayer plastic vial & syringe named OXYCAPT™ in 2019. It has achieved excellent oxygen, carbon dioxide & ultraviolet (UV) barrier, high water vapor barrier, very low extractables, high pH stability, low protein adsorption, high transparency, high break resistance, easier disposability, lighter weight, etc. OXYCAPT™ consists of three layers. The drug contact layer and the outer layer are made of cyclo-olefin polymer (COP), and the oxygen barrier layer is made of MGC’s novel polyester. The oxygen & carbon dioxide barrier of OXYCAPT™ vial is about 20 times better than that of COP monolayer vial. OXYCAPT™ also provides an excellent UV barrier. While about 70% of 300 nm UV light transmits through glass and COP, only 1.7% transmits through OXYCAPT™. OXYCAPT™ vial is produced by co-injection blow-molding technology. MGC has also developed inspection methods for testing the oxygen barrier layer. All of the containers are fully inspected by state-of-the-art inspection machinery. MGC can offer ready-to-use (RTU) vials in tray or nest & tub formats. The vials are mainly sterilized using gamma rays. There are 2, 6, 10 and 20 mL variants for vials. OXYCAPT™ vial is especially suitable for biologics and cell & gene therapy products stored at deep-cold or cryogenic temperature. It can maintain container closure integrity (CCI) under such harsh conditions and prevent carbon dioxide permeation generated from dry ice and nitrogen permeation from liquid nitrogen. As the carbon dioxide permeation usually causes pH shift and nitrogen permeation causes over-pressure in headspace, MGC believes OXYCAPT™ is an ideal solution for the drugs stored in dry ice and liquid nitrogen.

High quality single-use medical devices. Development, production, and registration – everything from one source for the global medical technology and pharmaceutical industry. Since the foundation of sfm medical devices GmbH in 1953, we, as a company, feel a responsibility to our employees, customers, suppliers, the environment, and society. Our precision single-use medical devices are used in many areas of human medicine and by the pharmaceutical industry. Numerous controlled manufacturing techniques and close collaboration amongst the different departments and subsidiaries results in outstanding quality. Mastering these collaborative efforts makes sfm unique in the market!